• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/30/23 1:18:58 PM ET
    $AKTS
    $ATXI
    $AULT
    $AWIN
    Telecommunications Equipment
    Utilities
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKTS alert in real time by email

     

    On Wednesday, 59 companies achieved new lows for the year.

    Interesting Points From Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Dollar Tree (NASDAQ:DLTR).
    • The company with the smallest market cap to set a new 52-week low was SenesTech (NASDAQ:SNES).
    • Outlook Therapeutics (NASDAQ:OTLK)'s stock fell the most, as it traded down 84.34% to reach a new 52-week low.
    • Dollar Tree (NASDAQ:DLTR)'s shares had the biggest turnaround, impressively rebounding 0.05% after reaching a new 52-week low.

    Here are all the stocks that set new 52-week lows on Wednesday:

    • Dollar Tree (NASDAQ:DLTR) shares moved up 0.05% on Wednesday to hit a new 52-week low of $122.00, drifting up 0.05%.
    • Hain Celestial Group (NASDAQ:HAIN) shares made a new 52-week low of $10.93 on Wednesday. The stock was up 0.32% for the day.
    • SIGNA Sports United (NYSE:SSU) shares set a new yearly low of $1.23 this morning. The stock was down 6.06% on the session.
    • Ioneer (NASDAQ:IONR) shares hit a yearly low of $6.21. The stock was down 2.59% on the session.
    • Vanda Pharma (NASDAQ:VNDA) stock hit a yearly low of $5.26. The stock was down 3.83% for the day.
    • noco-noco (NASDAQ:NCNC) stock hit a new 52-week low of $1.62. The stock was down 13.05% on the session.
    • Karyopharm Therapeutics (NASDAQ:KPTI) stock hit a new 52-week low of $1.33. The stock was up 1.84% on the session.
    • Satellogic (NASDAQ:SATL) stock set a new 52-week low of $1.51 on Wednesday, moving up 1.97%.
    • Faraday Future (NASDAQ:FFIE) shares were down 12.68% for the day, having made a 52-week low of $7.18.
    • Radcom (NASDAQ:RDCM) stock set a new 52-week low of $8.56 on Wednesday, moving up 1.24%.
    • Hawthorn Bancshares (NASDAQ:HWBK) shares were down 0.71% for the day, having made a 52-week low of $16.50.
    • Akoustis Technologies (NASDAQ:AKTS) shares hit a yearly low of $1.53. The stock was down 0.93% on the session.
    • Electrovaya (NASDAQ:ELVA) shares set a new yearly low of $3.18 this morning. The stock was down 3.32% on the session.
    • Complete Solaria (NASDAQ:CSLR) stock drifted down 5.6% on Wednesday morning to hit a new 52-week low of $2.13.
    • Outlook Therapeutics (NASDAQ:OTLK) shares made a new 52-week low of $0.21 on Wednesday. The stock was down 84.34% for the day.
    • Marketwise (NASDAQ:MKTW) shares set a new yearly low of $1.24 this morning. The stock was up 0.78% on the session.
    • SEALSQ (NASDAQ:LAES) shares set a new 52-week low of $5.00. The stock traded down 14.67%.
    • BYND Cannasoft Enterprise (NASDAQ:BCAN) shares made a new 52-week low of $0.85 on Wednesday. The stock was up 1.38% for the day.
    • Kentucky First Federal (NASDAQ:KFFB) stock dropped to a yearly low on Wednesday of $5.21. Shares traded down 4.58%.
    • TD Hldgs (NASDAQ:GLG) stock set a new 52-week low of $0.20 on Wednesday, moving down 28.45%.
    • Electra Battery Materials (NASDAQ:ELBM) shares set a new 52-week low of $0.65. The stock traded up 0.59%.
    • 22nd Century Group (NASDAQ:XXII) stock hit $1.56 on Wednesday morning, setting a new 52-week low for a change of down 4.71%.
    • USD Partners (NYSE:USDP) shares fell to $0.64 on Wednesday, setting a new 52-week low with a shift of down 1.99%.
    • Fusion Fuel Green (NASDAQ:HTOO) stock broke to a new 52-week low of $1.42 on Wednesday. Shares of the company traded down 16.09%.
    • BM Technologies (AMEX:BMTX) shares hit a yearly low of $1.62. The stock was up 0.61% on the session.
    • AERWINS Technologies (NASDAQ:AWIN) shares fell to $0.19 on Wednesday, setting a new 52-week low with a shift of down 0.9%.
    • Lightning eMotors (NYSE:ZEV) stock hit $1.93 on Wednesday morning, setting a new 52-week low for a change of down 1.05%.
    • Alkaline Water Co (NASDAQ:WTER) shares set a new yearly low of $0.86 this morning. The stock was down 0.13% on the session.
    • Pulmatrix (NASDAQ:PULM) stock hit a new 52-week low of $2.33. The stock was up 2.76% on the session.
    • Avalon Holdings (AMEX:AWX) shares hit a yearly low of $2.16. The stock was down 3.94% on the session.
    • Innovative Eyewear (NASDAQ:LUCY) shares hit a yearly low of $0.58. The stock was down 2.3% on the session.
    • Jaguar Health (NASDAQ:JAGX) shares fell to $0.38 on Wednesday, setting a new 52-week low with a shift of down 0.26%.
    • Avenue Therapeutics (NASDAQ:ATXI) stock drifted down 5.42% on Wednesday morning to hit a new 52-week low of $0.80.
    • Medigus (NASDAQ:MDGS) shares made a new 52-week low of $3.70 on Wednesday. The stock was up 1.41% for the day.
    • Ault Alliance (AMEX:AULT) stock achieved a new 52-week low on Wednesday morning, hitting $1.03 and moving up 0.13%.
    • Ontrak (NASDAQ:OTRK) shares were down 3.54% for the day, having made a 52-week low of $1.04.
    • Biolase (NASDAQ:BIOL) stock hit $4.35 on Wednesday morning, setting a new 52-week low for a change of down 1.97%.
    • Jeffs Brands (NASDAQ:JFBR) stock broke to a new 52-week low of $0.48 on Wednesday. Shares of the company traded down 1.98%.
    • Hallmark Financial Servs (NASDAQ:HALL) stock hit a new 52-week low of $1.95. The stock was up 1.37% on the session.
    • 1847 Holdings (AMEX:EFSH) stock drifted up 0.15% on Wednesday morning to hit a new 52-week low of $0.09.
    • Shineco (NASDAQ:SISI) shares were down 6.78% for the day, having made a 52-week low of $0.13.
    • SenesTech (NASDAQ:SNES) shares moved down 5.09% on Wednesday to hit a new 52-week low of $0.55, drifting down 5.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $ATXI
    $AULT
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    SEALSQ Corp
    $LAES
    12/18/2025$7.00Overweight
    Cantor Fitzgerald
    Electrovaya Inc.
    $ELVA
    12/18/2025$14.00Outperform
    Oppenheimer
    Dollar Tree Inc.
    $DLTR
    12/4/2025$130.00 → $135.00Outperform
    Telsey Advisory Group
    Dollar Tree Inc.
    $DLTR
    11/13/2025$103.00Buy → Sell
    Goldman
    Vanda Pharmaceuticals Inc.
    $VNDA
    11/5/2025$11.00Buy
    B. Riley Securities
    Karyopharm Therapeutics Inc.
    $KPTI
    10/13/2025$15.00Neutral → Buy
    H.C. Wainwright
    Dollar Tree Inc.
    $DLTR
    10/7/2025$70.00Hold → Underperform
    Jefferies
    Dollar Tree Inc.
    $DLTR
    9/18/2025Peer Perform
    Wolfe Research
    More analyst ratings

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on SEALSQ Corp with a new price target

    Cantor Fitzgerald initiated coverage of SEALSQ Corp with a rating of Overweight and set a new price target of $7.00

    12/18/25 9:11:03 AM ET
    $LAES
    Semiconductors
    Technology

    Oppenheimer initiated coverage on Electrovaya with a new price target

    Oppenheimer initiated coverage of Electrovaya with a rating of Outperform and set a new price target of $14.00

    12/18/25 9:09:07 AM ET
    $ELVA

    Telsey Advisory Group reiterated coverage on Dollar Tree with a new price target

    Telsey Advisory Group reiterated coverage of Dollar Tree with a rating of Outperform and set a new price target of $135.00 from $130.00 previously

    12/4/25 8:18:38 AM ET
    $DLTR
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Large owner Galkin Vladimir

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/7/26 9:44:23 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    SEC Form 4 filed by Large owner Galkin Vladimir

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/2/26 4:20:57 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    SEC Form 4 filed by Large owner Galkin Vladimir

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    12/29/25 1:49:33 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 5 filed by Cohen David Eric

    5 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/9/26 8:24:37 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Abondano Joaquin increased direct ownership by 1,168% to 5,211 units (SEC Form 5)

    5 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/9/26 7:23:16 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Dabrowski Konrad increased direct ownership by 271% to 11,504 units (SEC Form 5)

    5 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/9/26 7:19:59 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-6) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-5) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

    Vida has partnered with Aktis since co-leading its Series A, supporting the company from discovery through IPO and establishing itself as one of Aktis' largest shareholders; Helen Kim, Vida Senior Managing Director, has served on the Board since 2021 Brian Goodman, Ph.D., Managing Director at Vida Ventures and Co-Founder of Aktis, served as founding Chief Operating Officer, helping to establish the company's early operational, scientific, and strategic foundation Vida Ventures ("Vida"), a next-generation life sciences venture firm, today congratulates Aktis Oncology (NASDAQ:AKTS), a clinical-stage biotechnology company advancing a pipeline of alpha-emitting radiopharmaceuticals for t

    1/9/26 12:58:00 PM ET
    $AKTS
    $LLY
    Telecommunications Equipment
    Utilities
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEALSQ and Kaynes SemiCon Reach Final Agreement to Develop a Sovereign Indian Post-Quantum Semiconductor Joint Venture in Alignment with MeitY

    Geneva, Switzerland, Jan. 09, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, and a subsidiary of WISeKey International Holding AG (NASDAQ:WKEY, SIX: WIHN)) ("WISeKey"), today announced that it has reached a final, binding agreement with Kaynes SemiCon to establish SEALKAYNESQ Ltd, a Joint Venture ("JV") in India. The JV is being formed with the objective of developing, personalizing, and deploying a Sovereign Indian Post-Quantum semiconductor platform, fully aligned with India's national digital sovereignty and security priorities,

    1/9/26 8:30:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    Satellogic Announces Seven-Figure Monitoring Agreement with Strategic Customer

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Satellogic Inc. ("Satellogic") (NASDAQ:SATL), a leader in high-performance Earth Observation ("EO") platforms that deliver unique sovereign solutions and AI-first monitoring, today announced a seven-figure agreement with a strategic customer to support continuous, high-frequency monitoring across a large portfolio of priority sites. The agreement reflects growing demand for Earth observation capabilities designed to operate persistently and at scale, supporting organizations that require continuous awareness rather than episodic data access. Under the agreement, Satellogic will provide daily revisit, high-resolution coverage, enabling consistent

    1/8/26 8:00:00 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $AKTS
    $ATXI
    $AULT
    $AWIN
    SEC Filings

    View All

    SEC Form 424B4 filed by Akoustis Technologies Inc.

    424B4 - Aktis Oncology, Inc. (0002035832) (Filer)

    1/9/26 5:01:39 PM ET
    $AKTS
    Telecommunications Equipment
    Utilities

    Amendment: SEC Form SCHEDULE 13G/A filed by Vanda Pharmaceuticals Inc.

    SCHEDULE 13G/A - Vanda Pharmaceuticals Inc. (0001347178) (Subject)

    1/9/26 4:23:37 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Karyopharm Therapeutics Inc.

    DEF 14A - Karyopharm Therapeutics Inc. (0001503802) (Filer)

    1/9/26 4:15:58 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development

    ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced it has appointed Laura Cantrell as Vice President of Corporate Strategy and Business Development. "We are very pleased to welcome Laura to Outlook Therapeutics at such a pivotal time in our evolution," said Bob Jahr, Chief Executive Officer of Outlook Therapeutics. "Laura's two decades of global biotechnology experience spanning corporate strategy, business development and portfolio leadership, and her proven ability to identify, evaluate and execute high-value

    1/6/26 8:35:00 AM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Hain Celestial Appoints Alison E. Lewis President and Chief Executive Officer

    HOBOKEN, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. ("Hain Celestial" or the "Company") (NASDAQ:HAIN), today announced that Alison E. Lewis has been appointed President and Chief Executive Officer, effective immediately. Ms. Lewis had been serving as Hain Celestial's Interim President and Chief Executive Officer since May 2025. Ms. Lewis will also continue in her role as a member of the Board of Directors (the "Board").Dawn Zier, Chair of the Board, said, "The Board has had the opportunity over the past few months to observe Alison in action. We are pleased with the bold moves she has already taken to reduce costs, the turnaround agenda she has put in place desi

    12/15/25 7:00:00 AM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    SEALSQ Appoints Rolf Gobet as Director of Its Geneva Quantum Center of Excellence

    Geneva, Switzerland, Dec. 12, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announces the appointment of Rolf Gobet as Director of its Geneva Quantum Center of Excellence. This appointment represents a major step forward in the development of the SEALSQ Quantum Corridor, an ambitious pan-European initiative designed to connect world-class research institutions, semiconductor hubs, industrial partners, and government agencies into a unified ecosystem focused on post-quantum cybersecurity and quantum-enabled innovation. The Gen

    12/12/25 1:00:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Financials

    Live finance-specific insights

    View All

    Outlook Therapeutics Reports Financial Results for Fiscal Year 2025

    ISELIN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced financial results for fiscal year 2025. Financial Highlights for the Fiscal Year Ended September 30, 2025 For the fiscal year ended September 30, 2025, Outlook Therapeutics reported net loss attributable to common stockholders of $62.4 million, or $1.79 per basic and diluted share, and $1.4 million of revenue. This compares with net loss attributable to common stockholders of $75.4 million, or $4.06 per basic and diluted share, and no revenue for the prior year.

    12/19/25 8:05:00 AM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dollar Tree, Inc. Reports Results for the Third Quarter Fiscal 2025

    Dollar Tree Same-Store Net Sales +4.2% Diluted Earnings per Share (EPS) from Continuing Operations of $1.20 Adjusted Diluted EPS from Continuing Operations of $1.21 Completed $1.5 Billion of Share Repurchases Year-to-Date Introducing Fourth Quarter Fiscal 2025 Outlook: 4% to 6% Comparable Store Net Sales Growth and $2.40 to $2.60 Adjusted EPS from Continuing Operations Revising Full-Year Fiscal 2025 Comparable Store Net Sales Growth Outlook Range to 5.0% to 5.5% and Net Sales Outlook Range to $19.35 to $19.45 Billion Increasing Full-Year Fiscal 2025 Adjusted EPS from Continuing Operations Outlook Range to $5.60 to $5.80 to Reflect Updated Operating Outlook and Year-to-Date Shar

    12/3/25 6:30:00 AM ET
    $DLTR
    Department/Specialty Retail Stores
    Consumer Discretionary

    Dollar Tree, Inc. to Host Third Quarter Earnings Conference Call

    Dollar Tree, Inc. (NASDAQ:DLTR), will report financial results for the third quarter 2025 ended November 1, 2025, before the stock market opens on Wednesday, December 3, 2025, followed by a conference call for investors and analysts at 8 a.m. EST. Chief Executive Officer Mike Creedon and Chief Financial Officer Stewart Glendinning will discuss the company's results and lead a question-and-answer session. WHEN: Wednesday, December 3, 2025   8 a.m. Eastern Time     DIAL-IN: Please dial (877) 407-3943 or (201) 689-8855 at least 10 minutes prior to the scheduled start time.     WEBCAST: Available on the investor rel

    11/19/25 6:30:00 AM ET
    $DLTR
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Fusion Fuel Green PLC

    SC 13G/A - Fusion Fuel Green PLC (0001819794) (Subject)

    12/11/24 4:02:05 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13D filed by Fusion Fuel Green PLC

    SC 13D - Fusion Fuel Green PLC (0001819794) (Filed by)

    12/6/24 6:06:39 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13G filed by Fusion Fuel Green PLC

    SC 13G - Fusion Fuel Green PLC (0001819794) (Subject)

    12/3/24 4:00:02 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy